GE HealthCare’s MIM Software today announced it received FDA 510(k) clearance for Monte Carlo dosimetry. The latest clearance allows MIM Software to calculate radionuclide absorbed doses using a Monte Carlo method. Dosimetry will be available through the Dose Planning Method (DPM) and MIM SurePlan MRT, MIM Software’s solution for automating and standardizing dosimetry in theranostics. […]
MIM Software
GE HealthCare introduces new software for prostate cancer treatments
GE HealthCare (Nasdaq:GEHC) announced that its MIM Software unit began rolling out its new MIM Symphony HDR Prostate solution. MIM Symphony HDR supports high dose-rate (HDR) brachytherapy with direct tumor visualization from MRI scans during live ultrasound procedures for HDR prostate treatments. The technology corrects MRI orientation and offers MRI guidance during HDR prostate procedures. […]
GE HealthCare adds MIM Software to Elekta collaboration
GE HealthCare announced today that it expanded its relationship with Elekta with more collaboration on software for radiation oncology. Together, the companies aim to accelerate innovation in software to improve workflows, increase throughput and enhance user experience. They expect to enable greater precision in radiation therapy treatment with less time at the hospital for patients. […]
GE HealthCare closes MIM Software acquisition
GE HealthCare this week announced it closed its acquisition of MIM Software. The Chicago-based imaging company previously announced the buy in January. GE HealthCare funded the acquisition — for which financial terms were not disclosed — with cash on hand. MIM Software provides AI-based software for radiation oncology, molecular radiotherapy, diagnostic imaging and urology. The […]
GE HealthCare to acquire AI imaging analysis company MIM Software
GE HealthCare announced today that it agreed to acquire AI and medical imaging analysis provider MIM Software. GE HealthCare plans to fund the acquisition — for which financial terms were not disclosed — with cash on hand. MIM Software provides AI-based software for radiation oncology, molecular radiotherapy, diagnostic imaging and urology. The Cleveland-based company’s offerings […]
5 medtech stories we missed this week: July 6, 2018
From Zetta getting FDA clearance to Prescient Medical receiving CE Mark approval, here are five medtech stories we missed this week but thought were still worth mentioning. 1. Zetta wins FDA clearance for Zoom MRI software Zetta announced in a June 25 press release that its MRI software has received FDA 510(k) clearance. The software, known […]
Medtronic wins 510(k) for surgical sealer | Regulatory Roundup
Medtronic (NYSE:MDT) won 510(k) clearance from the FDA for the Aquamantys surgical sealer it acquired when it paid $480 million for Salient Surgical Technologies last year.
FDA approves AtriCure’s Synergy cardiac ablation device | Regulatory Roundup
AtriCure (NSDQ:ATRC) shares got a modest bump today after revealing pre-market approval from the FDA for its Synergy radiofrequency ablation system for atrial fibrillation.
ATRC shares were up 2.1% to $10.86 as of about 1 p.m. today.
MIM’s iPhone medical imaging device heads to the App Store
MIM Software Inc.’s diagnostic medical imaging app for the Apple Inc. (NSDQ:AAPL) iOS platform is now available for download.
The Food & Drug Administration-cleared diagnostic is the first-ever mobile radiology app to receive the agency’s seal of approval.
Mobile MIM’s long, strange trip
It took nearly three years and three 510(k) applications, but MIM Software finally won Food & Drug Administration clearance for its Mobile MIM app, the first-ever mobile radiology app to receive the agency’s seal of approval.
The process was so fraught with confusion and miscommunication — or worse, no communication — that MIM CTO Mark Cain likened the experience to falling into a "black hole."
